Relation between Escherichia coli K1 capsular polysaccharide antigen and clinical outcome in neonatal meningitis. 1974

G H McCracken, and L D Sarff, and M P Glode, and S G Mize, and M S Schiffer, and J B Robbins, and E C Gotschlich, and I Orskov, and F Orskov

UI MeSH Term Description Entries
D007106 Immune Sera Serum that contains antibodies. It is obtained from an animal that has been immunized either by ANTIGEN injection or infection with microorganisms containing the antigen. Antisera,Immune Serums,Sera, Immune,Serums, Immune
D007122 Immunoelectrophoresis A technique that combines protein electrophoresis and double immunodiffusion. In this procedure proteins are first separated by gel electrophoresis (usually agarose), then made visible by immunodiffusion of specific antibodies. A distinct elliptical precipitin arc results for each protein detectable by the antisera.
D007223 Infant A child between 1 and 23 months of age. Infants
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D007232 Infant, Newborn, Diseases Diseases of newborn infants present at birth (congenital) or developing within the first month of birth. It does not include hereditary diseases not manifesting at birth or within the first 30 days of life nor does it include inborn errors of metabolism. Both HEREDITARY DISEASES and METABOLISM, INBORN ERRORS are available as general concepts. Neonatal Diseases,Disease, Neonatal,Diseases, Neonatal,Neonatal Disease
D007235 Infant, Premature, Diseases Diseases that occur in PREMATURE INFANTS.
D008581 Meningitis Inflammation of the coverings of the brain and/or spinal cord, which consist of the PIA MATER; ARACHNOID; and DURA MATER. Infections (viral, bacterial, and fungal) are the most common causes of this condition, but subarachnoid hemorrhage (HEMORRHAGES, SUBARACHNOID), chemical irritation (chemical MENINGITIS), granulomatous conditions, neoplastic conditions (CARCINOMATOUS MENINGITIS), and other inflammatory conditions may produce this syndrome. (From Joynt, Clinical Neurology, 1994, Ch24, p6) Pachymeningitis,Meningitides,Pachymeningitides
D009345 Neisseria meningitidis A species of gram-negative, aerobic BACTERIA. It is a commensal and pathogen only of humans, and can be carried asymptomatically in the NASOPHARYNX. When found in cerebrospinal fluid it is the causative agent of cerebrospinal meningitis (MENINGITIS, MENINGOCOCCAL). It is also found in venereal discharges and blood. There are at least 13 serogroups based on antigenic differences in the capsular polysaccharides; the ones causing most meningitis infections being A, B, C, Y, and W-135. Each serogroup can be further classified by serotype, serosubtype, and immunotype. Diplokokkus intracellularis meningitidis,Meningococcus,Micrococcus intracellularis,Micrococcus meningitidis,Micrococcus meningitidis cerebrospinalis,Neisseria weichselbaumii
D011135 Polysaccharides, Bacterial Polysaccharides found in bacteria and in capsules thereof. Bacterial Polysaccharides
D004926 Escherichia coli A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc. Alkalescens-Dispar Group,Bacillus coli,Bacterium coli,Bacterium coli commune,Diffusely Adherent Escherichia coli,E coli,EAggEC,Enteroaggregative Escherichia coli,Enterococcus coli,Diffusely Adherent E. coli,Enteroaggregative E. coli,Enteroinvasive E. coli,Enteroinvasive Escherichia coli

Related Publications

G H McCracken, and L D Sarff, and M P Glode, and S G Mize, and M S Schiffer, and J B Robbins, and E C Gotschlich, and I Orskov, and F Orskov
May 1974, The New England journal of medicine,
G H McCracken, and L D Sarff, and M P Glode, and S G Mize, and M S Schiffer, and J B Robbins, and E C Gotschlich, and I Orskov, and F Orskov
January 1988, Reviews of infectious diseases,
G H McCracken, and L D Sarff, and M P Glode, and S G Mize, and M S Schiffer, and J B Robbins, and E C Gotschlich, and I Orskov, and F Orskov
April 1980, Infection and immunity,
G H McCracken, and L D Sarff, and M P Glode, and S G Mize, and M S Schiffer, and J B Robbins, and E C Gotschlich, and I Orskov, and F Orskov
August 1977, The Journal of infectious diseases,
G H McCracken, and L D Sarff, and M P Glode, and S G Mize, and M S Schiffer, and J B Robbins, and E C Gotschlich, and I Orskov, and F Orskov
June 1982, The American journal of medicine,
G H McCracken, and L D Sarff, and M P Glode, and S G Mize, and M S Schiffer, and J B Robbins, and E C Gotschlich, and I Orskov, and F Orskov
November 1987, Infection and immunity,
G H McCracken, and L D Sarff, and M P Glode, and S G Mize, and M S Schiffer, and J B Robbins, and E C Gotschlich, and I Orskov, and F Orskov
July 2014, Journal of neuroimmunology,
G H McCracken, and L D Sarff, and M P Glode, and S G Mize, and M S Schiffer, and J B Robbins, and E C Gotschlich, and I Orskov, and F Orskov
March 1979, The Journal of experimental medicine,
G H McCracken, and L D Sarff, and M P Glode, and S G Mize, and M S Schiffer, and J B Robbins, and E C Gotschlich, and I Orskov, and F Orskov
November 1997, Journal of clinical microbiology,
G H McCracken, and L D Sarff, and M P Glode, and S G Mize, and M S Schiffer, and J B Robbins, and E C Gotschlich, and I Orskov, and F Orskov
January 1982, Medicina,
Copied contents to your clipboard!